CXCL13 and myasthenia gravis: TECs from MG patients produce excessive amounts of cytokines (IL-6 and IL-1β), chemokines (CXCL13 and RANTES), as well as kinases (p38 and ERK1/2 MAPKs) (15, 42– 44).